Retracted: Promoter Methylation of theRASSF1AGene may Contribute to Colorectal Cancer Susceptibility: A Meta-Analysis of Cohort Studies
Authors:
- 13 March 2014
- journal article
- retracted article
- Published by Wiley in Annals of Human Genetics
- Vol. 78 (3) , 208-216
Abstract
This meta-analysis of published cohort studies was conducted to evaluate whether promoter methylation of the RASSF1A gene contributes to colorectal cancer (CRC) susceptibility. A range of electronic databases were searched without language restrictions. Meta-analysis was conducted using the STATA 12.0 software. Crude risk differences (RD) with their 95% confidence intervals (95%CI) were calculated. In this meta-analysis, 11 clinical cohort studies with a total of 630 CRC patients were included. The pooled results revealed that the frequency of RASSF1A gene methylation in cancer tissues was significantly higher than that in benign, adjacent, and normal tissues (cancer tissues vs. benign tissues: RD = 0.25, 95%CI = 0.13-0.38, P < 0.001; cancer tissues vs. adjacent tissues: RD = 0.32, 95%CI: 0.20-0.45, P < 0.001; cancer tissues vs. normal tissues: RD = 0.38, 95%CI: 0.26-0.50, P < 0.001; respectively). Subgroup analysis by ethnicity demonstrated that RASSF1A promoter methylation also exhibited a higher frequency in cancer tissues among both Asians and Caucasians (all P < 0.05). Our meta-analysis has shown positive correlations between RASSF1A promoter methylation and CRC susceptibility. Thus, detection of RASSF1A promoter methylation may be utilized as a valuable diagnostic marker for CRC.Keywords
Funding Information
- Research Foundation of Science and Technology Agency of Liaoning Province (2011408004)
This publication has 26 references indexed in Scilit:
- Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian PopulationPLOS ONE, 2013
- Quantitative Analysis of Cancer-associated Gene Methylation Connected to Risk Factors in Korean Colorectal Cancer PatientsJournal of Preventive Medicine and Public Health, 2012
- The cellular functions of RASSF1A and its inactivation in prostate cancerJournal of Carcinogenesis, 2012
- Epigenetics and colorectal cancerNature Reviews Gastroenterology & Hepatology, 2011
- Cigarette Smoking, Genetic Variants in Carcinogen-metabolizing Enzymes, and Colorectal Cancer RiskAmerican Journal of Epidemiology, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancerBritish Journal of Cancer, 2006
- Comparison of Two Methods to Detect Publication Bias in Meta-analysisJAMA, 2006
- Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancerOncogene, 2002